Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

iproplatin

A synthetic second-generation platinum-containing compound related to cisplatin. Iproplatin binds to and forms DNA crosslinks and platinum-DNA adducts, resulting in DNA replication failure and cell death. Although less prone to glutathione inactivation compared to cisplatin, resistance to this agent has been observed in vitro due to repair of platination damage by tumor cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Abbreviation:	CHIP
Code name:	JM-9
Chemical structure:	(OC-6-33)-dichlorodihydroxybis(2-propanamine)platinum
IND number:	22794
NSC code:	256927

iproplatin

Search NCI's Drug Dictionary